FDMT4D Molecular Therapeutics, Inc.
NASDAQ · Industrials · Mid Cap · Mkt cap $2.1B · Vol 44.33M
$168.38
▲ +1.52% today
Fetching live price…
God's Eye forensics
Accounting quality and solvency screens. Anything that can't be computed from available filings data is left blank rather than estimated.
Piotroski F-Score
5/55
5 of 5 financial-health checks passed (4 checks need data this provider doesn't publish).
Altman Z-Score
Insufficient data—
Needs total assets, operating profit and debt — not published for this listing yet.
Beneish (earnings quality)
Insufficient data—
The full manipulation model needs two years of receivables, depreciation and accrual data, which isn't published for this listing.
Scores are free. The criteria-by-criteria breakdown — exactly which checks this company failed — is part of DeepScreen Pro.
Fundamental breakdown — raw ratios are free · fetching live data — showing modeled estimates for now
P/E Ratio (TTM)
Modeled18.8x
Fairly priced
Contextual insight — DeepScreen Pro
PEG Ratio
Modeled0.92
Undervalued vs. growth
Contextual insight — DeepScreen Pro
P/S Ratio
Modeled2.22x
Moderate
Contextual insight — DeepScreen Pro
P/B Ratio
Modeled5.28x
Premium to book
Contextual insight — DeepScreen Pro
EV/Revenue
Modeled2.56x
Moderate
Contextual insight — DeepScreen Pro
EV/EBITDA
Modeled10.7x
Fair
Contextual insight — DeepScreen Pro
ROE
Modeled28.1%
Excellent shareholder returns
Contextual insight — DeepScreen Pro
ROA
Modeled18.7%
Assets working hard
Contextual insight — DeepScreen Pro
ROCE
Modeled26.2%
High-quality compounder
Contextual insight — DeepScreen Pro
Debt / Equity
Modeled0.15x
Conservative balance sheet
Contextual insight — DeepScreen Pro
LT Debt / Equity
Modeled0.12x
Very low structural debt
Contextual insight — DeepScreen Pro
Payout Ratio
Modeled25%
Growth company — reinvesting most profit
Contextual insight — DeepScreen Pro
Operating Leverage
Modeled1.65x
Good upside gearing
Contextual insight — DeepScreen Pro
Company financials
- EPS (TTM)
- $8.96
- Revenue (TTM)
- $950M
- Net margin
- 11.8%
- EBITDA margin
- 23.9%
- Earnings growth
- 20.5%
- Dividend yield
- 1.33%
- Payout ratio
- 25%
- Debt / equity
- 0.15x
Live data hasn't loaded yet — figures shown are DeepScreen's modeled estimates.
FDMT live news
LIVELoading live headlines…